ECSP992834A - Sal de bisulfato del inhibidor de la vih proteasa - Google Patents

Sal de bisulfato del inhibidor de la vih proteasa

Info

Publication number
ECSP992834A
ECSP992834A ECSP992834A ECSP992834A EC SP992834 A ECSP992834 A EC SP992834A EC SP992834 A ECSP992834 A EC SP992834A EC SP992834 A ECSP992834 A EC SP992834A
Authority
EC
Ecuador
Prior art keywords
protease inhibitor
hiv protease
bisulphate salt
salt
bisulphate
Prior art date
Application number
Other languages
English (en)
Inventor
Madhusudhan Pudipeddi
Janak Singh
Mark D Lindrud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP992834 priority Critical patent/ECSP992834A/es
Publication of ECSP992834A publication Critical patent/ECSP992834A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La sal de bisulfato, caracterizada porque tiene la fórmula (gráfico), una forma de dosis farmacéutica, caracterizada porque tiene la sal de bisulfato de la reinvindicación 1 y un portador farmacéuticamente aceptable.
ECSP992834 1999-01-19 1999-01-19 Sal de bisulfato del inhibidor de la vih proteasa ECSP992834A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP992834 ECSP992834A (es) 1999-01-19 1999-01-19 Sal de bisulfato del inhibidor de la vih proteasa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP992834 ECSP992834A (es) 1999-01-19 1999-01-19 Sal de bisulfato del inhibidor de la vih proteasa

Publications (1)

Publication Number Publication Date
ECSP992834A true ECSP992834A (es) 1999-05-17

Family

ID=42043824

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP992834 ECSP992834A (es) 1999-01-19 1999-01-19 Sal de bisulfato del inhibidor de la vih proteasa

Country Status (1)

Country Link
EC (1) ECSP992834A (es)

Similar Documents

Publication Publication Date Title
ECSP034456A (es) Analogos de somatostatina
EA200600473A1 (ru) Твердая фармацевтическая дозированная форма
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
FI935778A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
FI915819L (fi) Hiv- proteas-inhibitorer.
FI923158A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoidossa
AR028423A1 (es) Inhibidores de la replicacion del hiv
CY1110492T1 (el) Αγγειογονικη δραστικοτητα των υποκατεστημενου αζωτου αναλογων θαλιδομιδης
NO893834L (no) Terapeutiske forbindelser for aids basert paa hemmere av hiv-protease.
FI906212A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDSin hoidossa
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
FI955315A7 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n ho itoon
BG103425A (en) Pharmaceutical composition
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
FI954580A7 (fi) HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon
AR029185A1 (es) Derivado de naftiridina
ATE429224T1 (de) Arzneizubereitungen enthaltend mindestens einen hiv preoteaseinhibitor
CY1120408T1 (el) Βελτιωμενες φαρμακοτεχνικες μορφες
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
FI935780A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
IT1314895B1 (it) Sistema modulare di carpenteria per una linea di macchine diconfezionamento, ad esempio per prodotti farmaceutici od altro
FI935779A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
IS6679A (is) Ný form (R)-N-[5-metýl-8-(4-metýlpíperasín-1-ýl)-1,2,3,4-tetrahýdró-2-naftýl]-4-morfólínóbensamíðs
ECSP992834A (es) Sal de bisulfato del inhibidor de la vih proteasa
HRP20040186B1 (en) Use of lhrh-antagonists for the improvement of t-cell mediated immunity